You must be signed in to view this page
Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL
Volume 5, Number 6 (Nov/Dec 2014)
DOI: 10.6004/jadpro.2014.5.6.6
